Ajinomoto Co (AJINY) AI Stock Analysis

• Market Cap: $26.86B
• Dividend Yield: 1.11%
• Average Volume (3M): 1.56K
• Price to Earnings (P/E): 20.4
• Beta (1Y): 0.53
• Revenue Growth: 2.69%
• EPS Growth: -17.14%
• Country: US
• Employees: 34,862
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.25
• Shares Outstanding: 977,735,600
• 10 Day Avg. Volume: 1,694
• 30 Day Avg. Volume: 1,561
• PEG Ratio: -0.72
• Price to Book (P/B): 3.95
• Price to Sales (P/S): 1.93
• P/FCF Ratio: 25.72
• Enterprise Value/Market Cap: 166.54
• Enterprise Value/Revenue: 2.87
• Enterprise Value/Gross Profit: 7.72
• Enterprise Value/Ebitda: 21.54
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 1
• EPS Forecast (FY): 0.83
• Revenue Forecast (FY): $10.08B

• Rating: 62 Neutral
• Price Target: $31.00 ▲(48.40% Upside)
• Action: Reiterated Date: 02/08/26
• Date: Action: Reiterated 02/08/26

The score is held back primarily by rich valuation (high P/E with a modest yield). Financial performance is steady overall—good revenue and gross margin trends, moderate leverage, and positive free cash flow—but weaker cash conversion and some net margin pressure reduce confidence. Technically, the trend is positive, yet overbought momentum indicators suggest higher near-term downside risk.

Positive Factors

Diversified business model

Ajinomoto's multi-segment model (food products plus amino acids, pharmaceuticals and specialty chemicals) and broad international footprint create durable revenue diversification. This reduces single-market cyclicality, supports steady demand, and enables cross-segment R&D and distribution leverage over months to years.

Revenue growth and gross margin

Consistent TTM revenue growth and a rising gross margin indicate structural pricing power or better mix and cost control. Improved gross margin supports sustainable operating profitability across cycles and gives management scope to invest in growth or absorb input inflation without immediate margin erosion.

Solid balance sheet

Moderate leverage and substantial equity provide financial flexibility for capex, M&A, or R&D while maintaining credit resilience. Returns on equity near 10–11% suggest the business generates acceptable shareholder returns, enabling strategic investments without immediately compromising balance-sheet stability.

Negative Factors

Net margin compression

A sustained decline in net margin to ~5% signals pressure on bottom-line profitability despite stable gross margin. Over the medium term this reduces retained earnings available for reinvestment or shareholder returns and increases sensitivity to cost inflation or competitive price pressure absent structural margin recovery.

Mixed cash conversion

FCF covering only ~50–60% of net income indicates weaker cash conversion driven by working-capital swings or timing. Over months this can constrain internally funded growth, dividend consistency or buybacks and force reliance on external financing for investments, reducing balance-sheet optionality.

Rising leverage trend

An observable increase in leverage versus FY2023, even if moderate today, reduces cushion for adverse shocks and raises interest-cost sensitivity. If the trend continues it will limit strategic flexibility for M&A or investment and magnify risks from rate rises or margin pressure over the medium term.

Ajinomoto Co Business Overview & Revenue Model

Company Description

Ajinomoto Co., Inc. engages in the seasonings and foods, frozen foods, and healthcare and other businesses in Japan and internationally. Its Seasonings and Foods segment offers sauces and seasonings products under the AJI-NO-MOTO, HON-DASHI, Cook Do, Ajinomoto KK Consommé, Pure Select Mayonnaise, Ros Dee, Masako, Aji-ngon, Sazón, Sajiku, and CRISPY FRY names; and solutions and ingredients to consumer foods and food service industries. This segment also provides instant noodles under the Knorr Cup Soup, and YumYum names; coffee under the Birdy and Blendy brands; powdered drink under the Birdy 3in1 name; MAXIM products; Chyotto Zeitakuna Kohiten products; and gift sets and office supplies comprising coffee vending machines, tea server, etc. The Frozen Foods segment offers Chinese dumplings, cooked rice, noodles, desserts, shumai, processed chicken, and other products. The Healthcare and Other segment provides amino acids to various industries, such as pharmaceuticals, foods, and cosmetics; sports nutrition products; personal care ingredients; and sterile products, as well as engages in the provision of contract manufacturing services for pharmaceutical intermediates and active ingredients. This segment also offers Ajinomoto Build-up Film, an interlayer insulating material for semiconductor packages. Ajinomoto Co., Inc. was founded in 1909 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Ajinomoto generates revenue through multiple key streams, primarily from its food products and amino acid segments. The food products division contributes significantly through the sale of seasonings, sauces, and frozen foods, catering to both retail and food service markets. The amino acids segment earns income by supplying essential amino acids and other bio-based products to pharmaceutical and cosmetic industries, as well as to animal feed manufacturers. Additionally, Ajinomoto's partnerships with various food manufacturers and distributors enhance its market reach and facilitate joint product development. The company also invests in research and development to innovate and expand its product offerings, which contributes to sustaining its revenue growth. International operations further diversify its income sources, as the company has established a strong presence in North America, Europe, and Asia.

Ajinomoto Co Financial Statement Overview

Summary

Income statement strength (78) from strong TTM revenue growth and slightly better gross margin is tempered by net margin compression versus prior years. Balance sheet is solid (72) with moderate leverage, though leverage has risen versus FY2023. Cash flow is the main drag (63) due to mixed cash conversion (FCF only a bit over half of net income) despite positive OCF/FCF.

Income Statement

TTM (Trailing-Twelve-Months) revenue is up strongly versus the last annual period, and gross margin has improved (about 37% TTM vs ~36% in FY2025), showing decent pricing/mix and cost control. However, profitability is mid-single-digit, with net margin around 5% TTM and below the ~6–7% level seen in FY2022–FY2024, indicating some recent margin pressure despite stable operating margin near ~8%.

Balance Sheet

Leverage is moderate with debt running at roughly 0.6x equity in both TTM (Trailing-Twelve-Months) and the latest annual report, and equity remains substantial relative to the asset base. The main watch-out is the upward shift in leverage versus FY2023 (when debt-to-equity was notably lower), while returns on equity are solid but not accelerating (roughly ~10–11% recently).

Cash Flow

Cash generation is positive with TTM (Trailing-Twelve-Months) operating cash flow and free cash flow both solidly positive, and free cash flow growth close to flat year-over-year. That said, cash conversion is somewhat mixed: free cash flow covers only a bit more than half of net income in TTM, and operating cash flow relative to sales is modest, suggesting working-capital or cash-timing swings that can dampen consistency.

Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	1.56T	1.53T	1.44T	1.36T	1.15T	1.07T
Gross Profit	579.58B	550.76B	511.45B	470.39B	425.90B	406.22B
EBITDA	207.71B	209.22B	219.41B	202.42B	188.15B	168.89B
Net Income	78.61B	70.27B	87.12B	94.06B	75.72B	59.42B
Balance Sheet
Total Assets	1.90T	1.72T	1.77T	1.51T	1.46T	1.43T
Cash, Cash Equivalents and Short-Term Investments	201.98B	182.77B	194.19B	145.09B	169.26B	193.69B
Total Debt	447.24B	455.35B	491.68B	288.56B	313.91B	350.42B
Total Liabilities	1.08T	907.86B	890.43B	688.77B	717.32B	763.44B
Stockholders Equity	744.06B	746.80B	814.69B	768.68B	686.91B	620.26B
Cash Flow
Free Cash Flow	129.75B	114.81B	96.05B	44.59B	64.86B	79.61B
Operating Cash Flow	229.65B	209.90B	168.07B	117.64B	145.58B	165.65B
Investing Cash Flow	-79.63B	-77.38B	-132.43B	-30.09B	-61.57B	-66.25B
Financing Cash Flow	-183.63B	-137.68B	-6.75B	-111.06B	-123.06B	-60.39B

Ajinomoto Co Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 20.89
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AJINY, the sentiment is Positive. The current price of 20.89 is below the 20-day moving average (MA) of 29.24, below the 50-day MA of 26.02, and below the 200-day MA of 26.03, indicating a neutral trend. The MACD of 0.37 indicates Positive momentum. The RSI at 55.32 is Neutral, neither overbought nor oversold. The STOCH value of 69.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AJINY.

Ajinomoto Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HRL	68 Neutral	$12.50B	18.81	6.13%	4.82%	1.55%	-40.81%
MKC	65 Neutral	$14.78B	22.59	14.03%	2.61%	1.64%	-1.83%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
AJINY	62 Neutral	$26.86B	20.42	10.67%	1.11%	2.69%	-17.14%
GIS	62 Neutral	$20.06B	15.38	27.21%	5.19%	-5.65%	0.41%
SJM	61 Neutral	$10.81B	-3.86	-21.55%	4.45%	-0.66%	-326.55%
KHC	54 Neutral	$26.14B	-4.90	-13.44%	6.75%	-3.70%	-431.05%